Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM149404 (AVL-301 | CHEMBL3545308 | CNX-419 | CO-1686 | Roci...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM149404 (AVL-301 | CHEMBL3545308 | CNX-419 | CO-1686 | Roci...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM149404 (AVL-301 | CHEMBL3545308 | CNX-419 | CO-1686 | Roci...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228125 ((e)-n-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-et...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270538 (US10059688, Example 4 | US9783524, Example 4) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.08 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228117 ((e)-n-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM391733 (N-(3-((2-((4-(1-acetyl-1,2,3,6-tetrahydropyridin-4...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228126 ((e)-n-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-(2...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270544 (2-(2-(5-chloro-2-(4-(4- (dimethylamino)piperidin- ...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.13 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM391731 (US10300058, Compound 1 | pyrimidin-4-yl)amino)pyri...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228118 ((e)-n-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228109 ((e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-ethoxy...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM391732 (US10300058, Compound 2 | acrylamide ) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228124 ((e)-n-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-me...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228110 ((e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(((s)-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228127 ((e)-n-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-((...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM391735 (N-(6-((2-((4-(1-acetylpiperidin-4-yl)-2-methoxyphe...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228107 ( (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-metho...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 8.30 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228116 ((e)-n-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228111 ((e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(2-met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM391736 (N-(6-((2-((4-(1-acetyl-1,2,3,6-tetrahydropyridin-4...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397288 (US10596172, Compound I-3 | US10828300, Compound I-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene CAR LLC US Patent | Assay Description Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap... | US Patent US10596172 (2020) BindingDB Entry DOI: 10.7270/Q2VM4G9X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397144 (US10596172, Compound I-4 | US10828300, Compound I-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene CAR LLC US Patent | Assay Description Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap... | US Patent US10596172 (2020) BindingDB Entry DOI: 10.7270/Q2VM4G9X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397143 (US10596172, Compound I-8 | US10828300, Compound I-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals | Assay Description EGFR (WT) and EGFR (T790M/L858R): The Omnia Assay Protocol for potency assessment against EGFR is performed as described in Example 251 above except ... | Bioorg Med Chem 17: 3934-58 (2009) BindingDB Entry DOI: 10.7270/Q2NV9MM2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397288 (US10596172, Compound I-3 | US10828300, Compound I-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals | Assay Description EGFR (WT) and EGFR (T790M/L858R): The Omnia Assay Protocol for potency assessment against EGFR is performed as described in Example 251 above except ... | Bioorg Med Chem 17: 3934-58 (2009) BindingDB Entry DOI: 10.7270/Q2NV9MM2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397144 (US10596172, Compound I-4 | US10828300, Compound I-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals | Assay Description EGFR (WT) and EGFR (T790M/L858R): The Omnia Assay Protocol for potency assessment against EGFR is performed as described in Example 251 above except ... | Bioorg Med Chem 17: 3934-58 (2009) BindingDB Entry DOI: 10.7270/Q2NV9MM2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397173 (US10596172, Compound I-96 | US10828300, Compound I...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals | Assay Description EGFR (WT) and EGFR (T790M/L858R): The Omnia Assay Protocol for potency assessment against EGFR is performed as described in Example 251 above except ... | Bioorg Med Chem 17: 3934-58 (2009) BindingDB Entry DOI: 10.7270/Q2NV9MM2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397143 (US10596172, Compound I-8 | US10828300, Compound I-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene CAR LLC US Patent | Assay Description Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap... | US Patent US10596172 (2020) BindingDB Entry DOI: 10.7270/Q2VM4G9X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM397173 (US10596172, Compound I-96 | US10828300, Compound I...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene CAR LLC US Patent | Assay Description Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap... | US Patent US10596172 (2020) BindingDB Entry DOI: 10.7270/Q2VM4G9X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM195864 (US9670213, Compound 009 4-(dimethylamino)-N-(4-(2-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | 25 |
East China University of Science and Technology US Patent | Assay Description In vitro enzyme activity assay: wild-type and various mutants (T790M, L858R, L861Q, L858 R/T790M) EGFR, Z′-Lyte Kinase Assay Kit were purchased... | US Patent US9670213 (2017) BindingDB Entry DOI: 10.7270/Q23R0R1P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270543 (US10059688, Example 115 | US9783524, Example 115) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228113 ((e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(metho...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 12.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM391734 (N-(3-((2-((2-acetyl-7-methoxy-1,2,3,4-tetrahydrois...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research | Assay Description Test compounds: a part of compounds of the invention, the chemical names and preparation methods of which can be found in their preparation examples.... | Bioorg Med Chem Lett 19: 62-6 (2009) BindingDB Entry DOI: 10.7270/Q2P84F65 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228121 ((e)-n-(7-ethoxy-4-((1-(3-fluorobenzyl)-1h-indazol-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270540 (N-(3-(5-chloro-4-(2-(2- (dimethylamino)-2-oxoacety...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270542 (2-(2-(2-(4-acryloyl-3,4- dihydro-2H-benzo[b][1,4] ...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270541 (US10059688, Example 74) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228108 ((e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-methox...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM195861 (US9670213, Compound 006 N-(3-(2-(4-methoxyphenylam...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | 25 |
East China University of Science and Technology US Patent | Assay Description In vitro enzyme activity assay: wild-type and various mutants (T790M, L858R, L861Q, L858 R/T790M) EGFR, Z′-Lyte Kinase Assay Kit were purchased... | US Patent US9670213 (2017) BindingDB Entry DOI: 10.7270/Q23R0R1P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM378885 (US10266537, Compound 93) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Kalypsys, Inc. | Assay Description The aim of this experiment is to detect the inhibitory activity of the compounds of the present invention against in vitro protein kinases using isot... | Bioorg Med Chem Lett 17: 3562-9 (2007) BindingDB Entry DOI: 10.7270/Q21C2065 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228128 ((e)-n-(4-((3-chloro-2,4-difluorophenyl)amino)-7-me...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM5447 (CHEMBL939 | GEFITINIB | Iressa | N-(3-Chloro-4-flu...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE MMDB PC cid PC sid PDB UniChem Patents Similars | PDB US Patent | n/a | n/a | 22.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED US Patent | Assay Description The sample compounds were dissolved in DMSO and diluted it to 500 μM concentration with DMSO and transferred to a dose plate. The compounds were... | US Patent US10106508 (2018) BindingDB Entry DOI: 10.7270/Q26M38VB | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228112 ((e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(2,2,2...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22.6 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228120 ((e)-n-(4-((1-(3-fluorobenzyl)-1h-indazol-5-yl)amin...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22.9 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM270539 (2-(2-(5-chloro-2-(3-methoxy- 4-(4-methylpiperazin-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
BETTA PHARMACEUTICALS CO., LTD. US Patent | Assay Description TBD | US Patent US10059688 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NDZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM228115 ((e)-n-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 47.3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Materials used include HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Brij-35 (dodecyl polyglycol ether), DTT (dithiothreitol), EDTA (et... | US Patent US9556191 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM50171908 (CHEMBL3805238 | US10106508, Compound I-38) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED US Patent | Assay Description The sample compounds were dissolved in DMSO and diluted it to 500 μM concentration with DMSO and transferred to a dose plate. The compounds were... | US Patent US10106508 (2018) BindingDB Entry DOI: 10.7270/Q26M38VB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM50171880 (CHEMBL3804868 | US10106508, Compound I-37) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED US Patent | Assay Description The sample compounds were dissolved in DMSO and diluted it to 500 μM concentration with DMSO and transferred to a dose plate. The compounds were... | US Patent US10106508 (2018) BindingDB Entry DOI: 10.7270/Q26M38VB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM50171879 (CHEMBL3805774 | US10106508, Compound I-36) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED US Patent | Assay Description The sample compounds were dissolved in DMSO and diluted it to 500 μM concentration with DMSO and transferred to a dose plate. The compounds were... | US Patent US10106508 (2018) BindingDB Entry DOI: 10.7270/Q26M38VB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor [T790M] (Homo sapiens (Human)) | BDBM50171878 (CHEMBL3805039 | US10106508, Compound I-35) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED US Patent | Assay Description The sample compounds were dissolved in DMSO and diluted it to 500 μM concentration with DMSO and transferred to a dose plate. The compounds were... | US Patent US10106508 (2018) BindingDB Entry DOI: 10.7270/Q26M38VB | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 229 total ) | Next | Last >> |